Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
221 USD | +1.63% | +2.82% | -14.38% |
May. 03 | HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating | MT |
Apr. 30 | Wall Street: buoyed by Tesla, confident ahead of FOMC meeting | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.38% | 31.67B | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
+51.20% | 24.62B | |
-14.90% | 15.65B | |
-14.17% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B | |
-5.26% | 8.5B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen Secures European Marketing Approval for Multiple Sclerosis Treatment